COVID-19 impacts the expression of molecular markers associated with neuropsychiatric disorders.

MLA

Quincozes-Santos, André, et al. “COVID-19 Impacts the Expression of Molecular Markers Associated with Neuropsychiatric Disorders.” Brain, Behavior, & Immunity - Health, vol. 11, Feb. 2021, p. 100196. EBSCOhost, https://doi.org/10.1016/j.bbih.2020.100196.

APA

Quincozes-Santos, A., Rosa, R. L., Tureta, E. F., Bobermin, L. D., Berger, M., Guimarães, J. A., Santi, L., & Beys-da-Silva, W. O. (2021). COVID-19 impacts the expression of molecular markers associated with neuropsychiatric disorders. Brain, Behavior, & Immunity - Health, 11, 100196. https://doi.org/10.1016/j.bbih.2020.100196

Chicago

Quincozes-Santos, André, Rafael Lopes Rosa, Emanuela Fernanda Tureta, Larissa Daniele Bobermin, Markus Berger, Jorge Almeida Guimarães, Lucélia Santi, and Walter Orlando Beys-da-Silva. 2021. “COVID-19 Impacts the Expression of Molecular Markers Associated with Neuropsychiatric Disorders.” Brain, Behavior, & Immunity - Health 11 (February): 100196. doi:10.1016/j.bbih.2020.100196.